Product Name |
Afatinib imp-VI |
Alternate Names |
Afatinib Impurities, Impurities of Afatinib |
CAT No. |
CS-O-34830
|
CAS No. |
2223677-62-9 |
Category |
Impurities |
Stock |
IN-Stock
|
Mol. Wt. |
469.48 g/mol |
Mol. For. |
C₂₄H₂₅F₂N₅O₃
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Afatinib |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Afatinib imp-VI, also known as Afatinib Intermediate VI, is a chemical compound that plays a crucial role in the synthesis of Afatinib, a potent oral tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer. Afatinib imp-VI is a white to off-white powder that is soluble in organic solvents like methanol and acetonitrile.
In the pharmaceutical industry, Afatinib imp-VI is used as an intermediate in the synthesis of Afatinib. It acts as a key building block in the production of the final drug product by undergoing further chemical reactions. The purity of Afatinib imp-VI is an essential factor in the synthesis of the final drug product, and the compound must meet strict quality control standards.
Afatinib imp-VI has a complex chemical structure, consisting of multiple functional groups such as carboxylic acid, amide, and benzamide. The compound has a molecular formula of C25H22ClFN4O4 and a molecular weight of 496.92 g/mol.
In conclusion, Afatinib imp-VI is a critical intermediate in the synthesis of Afatinib, a drug used in the treatment of non-small cell lung cancer. The compound's chemical properties and purity are essential factors in the production of the final drug product, and it plays a significant role in the pharmaceutical industry.